ANGIOPATH TARGETED THERAPIES

Serial Number 76026044
606

Registration Progress

Application Filed
Apr 15, 2000
Under Examination
Nov 20, 2001
Approved for Publication
Aug 8, 2001
Published for Opposition
Aug 28, 2001
Registered

Trademark Image

ANGIOPATH TARGETED THERAPIES

Basic Information

Serial Number
76026044
Filing Date
April 15, 2000
Published for Opposition
August 28, 2001
Abandonment Date
May 21, 2002
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 21, 2002
Classes
005 010

Rights Holder

Edwards Lifesciences Corporation

03
Address
One Edwards Way
Irvine, CA 92614

Ownership History

Edwards Lifesciences Corporation

Original Applicant
03
Irvine, CA

Edwards Lifesciences Corporation

Owner at Publication
03
Irvine, CA

Legal Representation

Attorney
Peter J. Gluck

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Oct 10, 2002 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 20, 2001 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 28, 2001 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 8, 2001 NPUB O NOTICE OF PUBLICATION Loading...
Mar 29, 2001 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 27, 2001 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Mar 27, 2001 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
Sep 29, 2000 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 22, 2000 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
Sep 18, 2000 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
PHARMACEUTICALS PREPARATIONS FOR GROWING NEW BLOOD VESSELS IN ISCHEMIC HARD TISSUE
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
MEDICAL DEVICES, NAMELY, LASERS FOR CARDIOVASCULAR AND VASCULAR USE
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 010

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"TARGETED THERAPIES"